Alan MD - Timber Pharmaceuticals Ex Officer
TMBRDelisted Stock | USD 1.72 0.01 0.58% |
Insider
Alan MD is Ex Officer of Timber Pharmaceuticals
Age | 61 |
Phone | 973 314 9577 |
Web | https://www.timberpharma.com |
Timber Pharmaceuticals Management Efficiency
The company has return on total asset (ROA) of (1.3727) % which means that it has lost $1.3727 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (3.4324) %, meaning that it created substantial loss on money invested by shareholders. Timber Pharmaceuticals' management efficiency ratios could be used to measure how well Timber Pharmaceuticals manages its routine affairs as well as how well it operates its assets and liabilities.Timber Pharmaceuticals currently holds 331.15 K in liabilities with Debt to Equity (D/E) ratio of 0.06, which may suggest the company is not taking enough advantage from borrowing. Timber Pharmaceuticals has a current ratio of 2.4, suggesting that it is liquid enough and is able to pay its financial obligations when due. Note, when we think about Timber Pharmaceuticals' use of debt, we should always consider it together with its cash and equity.
Similar Executives
Showing other executives | INSIDER Age | ||
Justin Trojanowski | Tempest Therapeutics | 36 | |
James Collins | Senti Biosciences | 58 | |
Edward DVM | SAB Biotherapeutics | N/A | |
Maurice Zauderer | Vaccinex | 78 | |
Jeffrey Welch | GeoVax Labs | N/A | |
Philip Lee | Senti Biosciences | 42 | |
Christine MBA | SAB Biotherapeutics | 68 | |
Denise Carter | Quoin Pharmaceuticals Ltd | 55 | |
Mark Newman | GeoVax Labs | 69 | |
Jeffrey PharmD | Nutriband | 54 | |
Steven Reich | Artelo Biosciences | 78 | |
RAC Sakai | Tempest Therapeutics | N/A | |
MBA CFA | Vaccinex | 50 | |
Gordon JD | Quoin Pharmaceuticals Ltd | 60 | |
Gregory MBA | Artelo Biosciences | 61 | |
II MD | Entera Bio | 71 | |
Wilson Wong | Senti Biosciences | N/A | |
Anne Moon | Tempest Therapeutics | N/A | |
Michael Myers | Quoin Pharmaceuticals Ltd | 62 | |
MBA CMA | SAB Biotherapeutics | 69 | |
Elif McDonald | Curis Inc | N/A |
Management Performance
Return On Equity | -3.43 | |||
Return On Asset | -1.37 |
Timber Pharmaceuticals Management Team
Elected by the shareholders, the Timber Pharmaceuticals' board of directors comprises two types of representatives: Timber Pharmaceuticals inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Timber. The board's role is to monitor Timber Pharmaceuticals' management team and ensure that shareholders' interests are well served. Timber Pharmaceuticals' inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Timber Pharmaceuticals' outside directors are responsible for providing unbiased perspectives on the board's policies.
Alan MD, Ex Officer | ||
John MBA, CEO Chairman | ||
Joseph Lucchese, CFO, VP |
Timber Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is Timber Pharmaceuticals a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
Return On Equity | -3.43 | |||
Return On Asset | -1.37 | |||
Current Valuation | (916.94 K) | |||
Shares Outstanding | 3.43 M | |||
Shares Owned By Insiders | 1.11 % | |||
Shares Owned By Institutions | 7.78 % | |||
Number Of Shares Shorted | 7.91 K | |||
Price To Book | 6.94 X | |||
Price To Sales | 17.19 X | |||
Revenue | 83.18 K |
Pair Trading with Timber Pharmaceuticals
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Timber Pharmaceuticals position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Timber Pharmaceuticals will appreciate offsetting losses from the drop in the long position's value.Moving together with Timber Stock
Moving against Timber Stock
0.81 | KO | Coca Cola Sell-off Trend | PairCorr |
0.8 | MRK | Merck Company Fiscal Year End 6th of February 2025 | PairCorr |
0.73 | TLK | Telkom Indonesia Tbk | PairCorr |
0.66 | PPERY | Bank Mandiri Persero | PairCorr |
0.64 | PPERF | Bank Mandiri Persero | PairCorr |
The ability to find closely correlated positions to Timber Pharmaceuticals could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Timber Pharmaceuticals when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Timber Pharmaceuticals - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Timber Pharmaceuticals to buy it.
The correlation of Timber Pharmaceuticals is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Timber Pharmaceuticals moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Timber Pharmaceuticals moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Timber Pharmaceuticals can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Check out World Market Map to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in bureau of labor statistics. You can also try the Efficient Frontier module to plot and analyze your portfolio and positions against risk-return landscape of the market..
Other Consideration for investing in Timber Stock
If you are still planning to invest in Timber Pharmaceuticals check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Timber Pharmaceuticals' history and understand the potential risks before investing.
Money Managers Screen money managers from public funds and ETFs managed around the world | |
Bonds Directory Find actively traded corporate debentures issued by US companies | |
Headlines Timeline Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity | |
Volatility Analysis Get historical volatility and risk analysis based on latest market data | |
Competition Analyzer Analyze and compare many basic indicators for a group of related or unrelated entities | |
Global Markets Map Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes | |
Equity Forecasting Use basic forecasting models to generate price predictions and determine price momentum | |
Sectors List of equity sectors categorizing publicly traded companies based on their primary business activities | |
Technical Analysis Check basic technical indicators and analysis based on most latest market data |